MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.aohep.2022.100762

Медицинская библиотека · Annals of hepatology · 2022

Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis.

Muthiah Mark, Ng Cheng Han, Chan Kai En, Fu Clarissa Elysia, Lim Wen Hui, Tan Darren Jun Hao, Nah Benjamin, Kong Gwyneth, Xiao Jieling, Yong Jie Ning, Tan Bryan, Syn Nicholas, Wang Jiong-Wei, Sayed Nilofer, Tan Eunice, Chew Nicholas Ws, Dan Yock Young, Siddiqui Mohammad Shadab, Sanyal Arun J, Noureddin Mazen

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION AND

OBJECTIVES

Type 2 Diabetes Mellitus (T2DM) is comorbidity commonly presenting with fatty liver. A recently proposed definition of "metabolic associated fatty liver disease" (MAFLD) is thought to replace non-alcoholic fatty liver disease (NAFLD). Yet, despite the significant prevalence of T2DM among fatty liver, there remains limited evidence on the impact of the change in the definition of T2DM.

MATERIALS AND

METHODS

The current study uses data from the United States National Health and Nutrition Examination Survey (NHANES) from 1999 to 2018. Survival analysis was conducted with a cox regression and sub-distribution hazard ratio for competing risk events.

RESULTS

6727 patients had a diagnosis of T2DM. 4982 individuals with T2DM had MAFLD and 2032 were MAFLD(+)/NAFLD(-), while 2950 patients were MAFLD(+)/NAFLD(+). The new definition increased fatty liver diagnosis by 68.89%. Patients who were classified as MAFLD(+)/NAFLD(-) were at a higher risk of major adverse cardiovascular events, advanced fibrosis, all-cause and cardiovascular-related mortality compared to MAFLD(+)/NAFLD(+). In MAFLD(+)/NAFLD(-), viral hepatitis significantly increases the odds of advanced fibrosis (OR: 6.77, CI: 3.92 to 11.7, p < 0.001) and all-cause mortality (HR: 1.75, CI: 1.29 to 2.40, p < 0.001).

CONCLUSIONS

The identification and treatment of NAFLD in patients with T2DM is a major concern and the premature change to MAFLD results in an over-diagnosis of fatty liver, exaggerated mortality, and morbidity in patients with T2DM. The definition of MAFLD causes further heterogeneity in fatty liver disease/NAFLD.

Для цитирования: Muthiah Mark, Ng Cheng Han, Chan Kai En, Fu Clarissa Elysia, Lim Wen Hui, Tan Darren Jun Hao, Nah Benjamin, Kong Gwyneth, Xiao Jieling, Yong Jie Ning, Tan Bryan, Syn Nicholas, Wang Jiong-Wei, Sayed Nilofer, Tan Eunice, Chew Nicholas Ws, Dan Yock Young, Siddiqui Mohammad Shadab, Sanyal Arun J, Noureddin Mazen. Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis.. Annals of hepatology. 2022. DOI: 10.1016/j.aohep.2022.100762.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.